We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
-12.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$94.5M
AUM Growth
-$43.8M
Cap. Flow
-$15M
Cap. Flow %
-15.87%
Top 10 Hldgs %
63.27%
Holding
99
New
7
Increased
9
Reduced
24
Closed
13

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.89M
2
DVN icon
Devon Energy
DVN
+$2.41M
3
QTEK
QualTek Services Inc. Class A Common Stock
QTEK
+$2.23M
4
LNTH icon
Lantheus
LNTH
+$1.5M
5
DOCN icon
DigitalOcean
DOCN
+$1.2M

Top Sells

Rank Stock Value
1
ARCT icon
Arcturus Therapeutics
ARCT
+$5.77M
2
UTHR icon
United Therapeutics
UTHR
+$2.92M
3
META icon
Meta Platforms (Facebook)
META
+$2.52M
4
VIR icon
Vir Biotechnology
VIR
+$2.43M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$1.87M

Sector Composition

Rank Sector Weight
1 Healthcare 75.56%
2 Technology 13.28%
3 Energy 4.44%
4 Financials 2.35%
5 Communication Services 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRIS icon
51
Curis
CRIS
$8.85M
$190K 0.2%
200
– –
ADAP
52
DELISTED
Adaptimmune Therapeutics
ADAP
$185K 0.2%
90,000
– –
SEGG
53
Sports Entertainment Gaming Global Corp
SEGG
$8.64M
$176K 0.19%
40
-4
-9% -$22.9K
ORIO
54
Orion Digital Corp
ORIO
$15.6M
$160K 0.17%
18,333
– –
OYST
55
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$157K 0.17%
13,500
– –
MRKR icon
56
Marker Therapeutics
MRKR
$19M
$156K 0.17%
35,440
– –
CLRB icon
57
Cellectar Biosciences
CLRB
$20.1M
$150K 0.16%
725
– –
ABTC
58
American Bitcoin Corp
ABTC
$477M
$146K 0.15%
4
– –
RNAZ icon
59
TransCode Therapeutics
RNAZ
$4.5M
– –
0
– –
AKRO
60
DELISTED
Akero Therapeutics
AKRO
$142K 0.15%
10,000
-3,500
-26% -$61.3K
ENLV icon
61
Enlivex Ltd
ENLV
$36.7M
$140K 0.15%
1,667
– –
AMPE
62
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$137K 0.14%
972
– –
YCBD icon
63
cbdMD
YCBD
$6.19M
$130K 0.14%
347
– –
HSDT icon
64
Solana Company
HSDT
$100M
$117K 0.12%
1
– –
CTSO icon
65
Cytosorbents Corp
CTSO
$24.2M
$112K 0.12%
35,000
– –
TIL icon
66
Instil Bio
TIL
$49.2M
$108K 0.11%
500
– –
SIOX
67
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$98K 0.1%
146,500
-38,500
-21% -$32.7K
ATRA icon
68
Atara Biotherapeutics
ATRA
$76.9M
$85K 0.09%
368
– –
SDPI
69
DELISTED
Superior Drilling Products Inc.
SDPI
$85K 0.09%
80,000
-27,500
-26% -$25.9K
SQZ
70
DELISTED
SQZ Biotechnologies Company
SQZ
$77K 0.08%
16,000
– –
TCON
71
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$75K 0.08%
1,425
– –
AVDL
72
DELISTED
Avadel Pharmaceuticals
AVDL
$72K 0.08%
10,500
– –
LTRYW icon
73
Sports Entertainment Gaming Global Corp Warrants
LTRYW
$785
$61K 0.06%
125,000
– –
YALA
74
Yalla Group
YALA
$815M
$60K 0.06%
13,500
– –
CYT
75
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$57K 0.06%
15,000
– –
1 2
3
4

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, ACT Capital Management held 99 positions worth $94.5M, down 32% from $138M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

ACT Capital Management withdrew a net $15M in Q1 2022, closing 13 positions and reducing 24 holdings. Its most notable exit was United Therapeutics, an estimated $2.92M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 82% a quarter earlier, followed by Technology and Energy.

Against the trend, ACT Capital Management opened a new position in NVIDIA worth $4.23M.

  • ACT Capital Management's largest Q1 2022 buy was NVIDIA: 155,000 shares worth $4.23M.
  • ACT Capital Management added most to DigitalOcean in Q1 2022, an estimated $1.2M increase.
  • ACT Capital Management's biggest Q1 2022 reduction was Arcturus Therapeutics, cutting an estimated $5.77M.
  • ACT Capital Management fully exited United Therapeutics in Q1 2022, selling an estimated $2.92M.
  • ACT Capital Management's ten largest holdings make up 63% of its $94.5M portfolio in Q1 2022.
  • ACT Capital Management opened 7 new positions and closed 13 in Q1 2022.
  • ACT Capital Management's portfolio value fell 32% quarter-over-quarter to $94.5M.

Based on ACT Capital Management's 13F filing for Q1 2022, filed 11 May 2022.